Kura Oncology, Inc. (KURA) is a clinical-stage biopharmaceutical company developing targeted therapies for cancer. Its precision medicine approach focuses on genetic and molecular drivers of tumor growth, aiming to improve outcomes for patients with hard-to-treat cancers. Kura’s growth is fueled by progress in its oncology pipeline, advancing clinical trials for oral inhibitors, and expanding partnerships focused on next-generation cancer treatments.
On the chart, a confirmation bar with rising volume highlights bullish strength. The price has entered the momentum zone after moving above the .236 Fibonacci level. A trailing stop can be placed just below this Fibonacci line using the Fibonacci snap tool, helping traders lock in profits while leaving room for continued upside potential.
On the chart, a confirmation bar with rising volume highlights bullish strength. The price has entered the momentum zone after moving above the .236 Fibonacci level. A trailing stop can be placed just below this Fibonacci line using the Fibonacci snap tool, helping traders lock in profits while leaving room for continued upside potential.
Start Here
link.traderspro.com/start-here
Get The Trade Checklist
link.traderspro.com/checklist
Toolkit
link.traderspro.com/toolkit
Daily email newsletter
link.traderspro.com/dailytrade
link.traderspro.com/start-here
Get The Trade Checklist
link.traderspro.com/checklist
Toolkit
link.traderspro.com/toolkit
Daily email newsletter
link.traderspro.com/dailytrade
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Start Here
link.traderspro.com/start-here
Get The Trade Checklist
link.traderspro.com/checklist
Toolkit
link.traderspro.com/toolkit
Daily email newsletter
link.traderspro.com/dailytrade
link.traderspro.com/start-here
Get The Trade Checklist
link.traderspro.com/checklist
Toolkit
link.traderspro.com/toolkit
Daily email newsletter
link.traderspro.com/dailytrade
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.